Australia markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
503.04+0.44 (+0.09%)
As of 9:32AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close502.60
Open496.65
Bid499.00 x 800
Ask508.88 x 1100
Day's range502.05 - 503.75
52-week range441.00 - 664.64
Volume18,145
Avg. volume1,011,079
Market cap53.892B
Beta (5Y monthly)0.19
PE ratio (TTM)16.48
EPS (TTM)30.52
Earnings date06 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est643.36
  • 3 Cathie Wood Stocks You Can Buy at a Bargain Right Now
    Motley Fool

    3 Cathie Wood Stocks You Can Buy at a Bargain Right Now

    When Cathie Wood talks, investors listen. The founder of Ark Invest has successfully predicted stock market stars -- one of her top holdings is Tesla. Now, here's some great news for all of us who want to follow this investment superstar's lead: Right now, you can buy three of the biggest holdings in her Ark Genomic Revolution ETF at a bargain.

  • Could Vir Biotechnology Be a Millionaire Maker Stock?
    Motley Fool

    Could Vir Biotechnology Be a Millionaire Maker Stock?

    Vir Biotechnology (NASDAQ: VIR) may be weeks away from commercializing its very first product. The clinical-stage biotech company and partner GlaxoSmithKline late last month requested Emergency Use Authorization (EUA) for their investigational COVID-19 treatment. In more good news, GlaxoSmithKline recently expanded its collaboration with Vir to include the development of potential treatments for respiratory viruses including influenza.

  • Yahoo Finance Video

    Vaccinating kids will be very important in getting to herd immunity: Expert

    Kristen Choi, PhD, MS, RN, Assistant Professor, UCLA School of Nursing, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus.